ARROWHEAD PHARMACEUTICALS, INC. Capital Leases, Future Minimum Payments, Interest Included in Payments
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Capital Leases, Future Minimum Payments, Interest Included in Payments of $13.61 thousand as of 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments · last filed 2016-08-09
- 2016-06-30: Capital Leases, Future Minimum Payments, Interest Included in Payments $13.61K.
- 2016-03-31: Capital Leases, Future Minimum Payments, Interest Included in Payments $16.21K.
- 2015-12-31: Capital Leases, Future Minimum Payments, Interest Included in Payments $19.04K.
- 2015-09-30: Capital Leases, Future Minimum Payments, Interest Included in Payments $22.09K.
| Period end | Capital Leases, Future Minimum Payments, Interest Included in Payments |
|---|---|
| 2016-06-30 | $13.61K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $16.21K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $19.04K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $22.09K 10-K · filed 2015-12-14 |
| 2015-06-30 | $25.37K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $28.87K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $32.59K 10-Q · filed 2015-02-09 |
| 2014-09-30 | $36.52K 10-K · filed 2014-11-25 |
| 2014-06-30 | $40.68K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $45.05K 10-Q · filed 2014-05-06 |
| 2013-12-31 | $99.29K 10-Q · filed 2014-02-04 |
| 2013-09-30 | $108.79K 10-K · filed 2013-12-18 |
| 2013-06-30 | $118.70K 10-Q · filed 2013-08-07 |
| 2013-03-31 | $129.01K 10-Q · filed 2013-05-09 |
| 2012-12-31 | -$139.72K 10-Q · filed 2013-02-13 |
| 2012-09-30 | $150.84K 10-K · filed 2012-12-28 |
| 2012-06-30 | $162.34K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |